During the first half of 2025, seven A-share enterprises successfully listed in Hong Kong, raising over HK$77 billion, which constituted 72.2% of the total funds raised in the Hong Kong stock market. The trend of A+H share listings is poised to persist, fueled by the streamlined filing and approval process for A-share enterprises. Currently, healthcare and information technology companies account for an impressive 48% of listing applications at the Hong Kong Stock Exchange. Furthermore, the introduction of the "Tech-Specific Route" is anticipated to expedite the IPO process for tech and pharma enterprises in Hong Kong. Specifically, 22 enterprises are planning to list under the "18A" rule, while 12 enterprises aim to list under the "18C" rule.